On Oct. 3, a 3-year-old Percheron gelding in Pearl River County, Mississippi, tested positive for Eastern equine encephalitis ...

SAN FRANCISCO, Oct. 2, 2025 /PRNewswire/ -- Percheron Capital ("Percheron"), a leading private equity firm focused on partnering with high-quality essential services businesses, today announced the ...

The team bringing international dressage back to Hickstead from next year promise “an experience that will go beyond the arena and leave a legacy for years to come”. H&H reported last year that the ...

The maneuvers and jumps associated with high classical dressage were originally designed as equine military training to develop strength, agility, balance, concentration and focus on the rider’s ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Percheron Therapeutics ( (AU:PER)) has ...

Jane Kidd, the stalwart of British dressage died on 21 August, aged 82, following a long illness. Jane’s life was intertwined with horses from her earliest years, and she carried her love of the sport ...

What is the current share price of Percheron Therapeutics Limited (PER)? Percheron Therapeutics Limited's (PER) current share price is $0.01. This constitutes a price movement of 0% when compared to ...

Percheron Therapeutics (ASX: PER, formerly Antisense Therapeutics) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and ...

In all, 32 sports will be part of the program for the Paris 2024 Olympic Games. Each sport has its own international federation, and within a sport, several disciplines can coexist - such as road ...

Working animals, like therapy horses and military K9s, have irreplaceable jobs in their fields. In fact, they can become such beloved colleagues that, sometimes, that's all you can see! It can be easy ...

Mark Diamond has over 30 years of experience in the pharmaceutical and biotechnology industry. Before joining Antisense Therapeutics Limited as managing director and chief executive in October 2001, ...

Percheron Therapeutics has reported final results from the Phase I dose escalation study of HMBD-002, its monoclonal antibody targeting VISTA, a novel immune checkpoint protein. The data confirmed the ...